These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8629094)

  • 21. Factors attenuating growth promoting effect of growth hormone therapy for Turner's syndrome.
    Sato T; Miyamori C; Kajiwara S; Miyagawa K; Shimizu M
    Endocrinol Jpn; 1988 Oct; 35(5):725-31. PubMed ID: 3146501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Final height in Turner syndrome patients treated with growth hormone.
    Rochiccioli P; Battin J; Bertrand AM; Bost M; Cabrol S; le Bouc Y; Chaussain JL; Chatelain P; Colle M; Czernichow P
    Horm Res; 1995; 44(4):172-6. PubMed ID: 8522279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of Turner syndrome: correlation with clinical phenotype and response to growth hormone therapy.
    Tsezou A; Hadjiathanasiou C; Gourgiotis D; Galla A; Kavazarakis E; Pasparaki A; Kapsetaki M; Sismani C; Theodoridis C; Patsalis PC; Moschonas N; Kitsiou S
    Clin Genet; 1999 Dec; 56(6):441-6. PubMed ID: 10665663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome.
    Song Y; Yang H; Wang L; Gong F; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):465-471. PubMed ID: 33662192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the Treatment of Turner Syndrome.
    Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T; Hizuka N
    Horm Res; 1995; 43(4):141-3. PubMed ID: 7750916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C; Wit JM; De Muinck Keizer-Schrama SM; Otten BJ; Oostdijk W; Delemarre-van der Waal HA; Gons MH; Bot A; Van den Brande JL
    Eur J Pediatr; 1992 Jul; 151(7):477-81. PubMed ID: 1396905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological aspects of the Canadian randomized controlled trial of human growth hormone and low-dose ethinyl oestradiol in children with Turner syndrome. The Canadian Growth Hormone Advisory Group.
    Rovet J; Holland J
    Horm Res; 1993; 39 Suppl 2():60-4. PubMed ID: 8359791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome.
    Linglart A; Cabrol S; Berlier P; Stuckens C; Wagner K; de Kerdanet M; Limoni C; Carel JC; Chaussain JL;
    Eur J Endocrinol; 2011 Jun; 164(6):891-7. PubMed ID: 21398400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Price DA; Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():69-74. PubMed ID: 8219480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left middle finger metacarpophalangeal growth in Turner syndrome. Normal values and changes after growth hormone treatment.
    Chávez Meyer H; Ranke MB
    Horm Res; 1991; 35(3-4):109-12. PubMed ID: 1806463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum LH and FSH responses to synthetic LH-RH in normal infants, children and patients with Turner's syndrome.
    Suwa S; Maesaka H; Matsui I
    Pediatrics; 1974 Oct; 54(4):470-5. PubMed ID: 4607066
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methionyl human growth hormone in Turner's syndrome.
    Rongen-Westerlaken C; Wit JM; Drop SL; Otten BJ; Oostdijk W; Waal HA; Gons MH; Bot A; Van den Brande JL
    Arch Dis Child; 1988 Oct; 63(10):1211-7. PubMed ID: 3196048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
    Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome.
    Massa G; de Zegher F; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1991 Mar; 34(3):205-9. PubMed ID: 2036729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Height in Turner syndrome: does growth hormone therapy have impact?
    Nadeem M; Roche EF
    Ir Med J; 2014 Feb; 107(2):61-2. PubMed ID: 24654495
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
    Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
    Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.
    Pucarelli I; Segni M; Ortore M; Arcadi E; Pasquino AM
    J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1005-10. PubMed ID: 14513877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.